compoundinterest7

BCLI target price at $6.35 +24%

Long
NASDAQ:BCLI   Brainstorm Cell Therapeutics Inc
Brainstorm Cell Therapeutics has activated a falling wedge with price target at $6.35 +24% from current price and also deactivated a second bearish impulse.
Trade closed: target reached